We are looking for companies interested in using our proprietary technology in the development programs, where compound targeted delivery is crucial. This new generation of cell based therapy has the potential of fast track regulatory pathway due to maintenance of natural cell features while uploaded with necessary molecules.


Aktualnie poszukujemy osoby na stanowisko: